-
1.
公开(公告)号:US08691184B2
公开(公告)日:2014-04-08
申请号:US13356763
申请日:2012-01-24
申请人: Shaomeng Wang , Haibin Zhou , Jianfang Chen , Angelo Aguilar , Jennifer L. Meagher , Duxin Sun , Chao-Yie Yang , Liu Liu , Longchuan Bai , Donna McEachem , Jeanne Stuckey , Xiaoqin Li
发明人: Shaomeng Wang , Haibin Zhou , Jianfang Chen , Angelo Aguilar , Jennifer L. Meagher , Duxin Sun , Chao-Yie Yang , Liu Liu , Longchuan Bai , Donna McEachem , Jeanne Stuckey , Xiaoqin Li
IPC分类号: A61K51/00 , A61K31/5377 , A61K31/496 , C07D413/14 , C07D403/12 , C07D401/14 , C07D403/10 , C07D405/10 , A61P35/00 , A61K31/5513 , C07D471/04
CPC分类号: C07D239/28 , C07D207/34 , C07D231/12 , C07D233/28 , C07D233/56 , C07D261/08 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D471/04
摘要: Inhibitors of Bcl-2/Bcl-xL and compositions containing the same are disclosed. Methods of using the Bcl-2/Bcl-xL inhibitors in the treatment of diseases and conditions wherein inhibition of Bcl-2/Bcl-xL provides a benefit, like cancers, also are disclosed.
摘要翻译: 公开了Bcl-2 / Bcl-xL的抑制剂及其组合物。 还公开了使用Bcl-2 / Bcl-xL抑制剂治疗其中Bcl-2 / Bcl-xL的抑制提供益处的疾病和病症的方法,如癌症。
-
2.
公开(公告)号:US20120189539A1
公开(公告)日:2012-07-26
申请号:US13356763
申请日:2012-01-24
申请人: Shaomeng Wang , Haibin Zhou , Jianfang Chen , Angelo Aguilar , Jennifer L. Meagher , Duxin Sun , Chao-Yie Yang , Liu Liu , Longchuan Bai , Donna McEachem , Jeanne Stuckey , Xiaoqin Li
发明人: Shaomeng Wang , Haibin Zhou , Jianfang Chen , Angelo Aguilar , Jennifer L. Meagher , Duxin Sun , Chao-Yie Yang , Liu Liu , Longchuan Bai , Donna McEachem , Jeanne Stuckey , Xiaoqin Li
IPC分类号: A61K51/00 , A61K31/5377 , A61K31/496 , C07D413/14 , C07D403/12 , C07D401/14 , C07D403/10 , C07D405/10 , A61P35/00 , A61K31/5513 , C07D471/04
CPC分类号: C07D239/28 , C07D207/34 , C07D231/12 , C07D233/28 , C07D233/56 , C07D261/08 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D471/04
摘要: Inhibitors of Bcl-2/Bcl-xL and compositions containing the same are disclosed. Methods of using the Bcl-2/Bcl-xL inhibitors in the treatment of diseases and conditions wherein inhibition of Bcl-2/Bcl-xL provides a benefit, like cancers, also are disclosed.
摘要翻译: 公开了Bcl-2 / Bcl-xL的抑制剂及其组合物。 还公开了使用Bcl-2 / Bcl-xL抑制剂治疗其中Bcl-2 / Bcl-xL的抑制提供益处的疾病和病症的方法,如癌症。
-
3.
公开(公告)号:US20120302629A1
公开(公告)日:2012-11-29
申请号:US13388610
申请日:2010-07-28
申请人: Shaomeng Wang , Feng Jiang , Jianting Long , Longchuan Bai
发明人: Shaomeng Wang , Feng Jiang , Jianting Long , Longchuan Bai
IPC分类号: A61K31/11 , C12Q1/68 , A61P35/00 , A61K31/337 , A61P29/00 , A61P31/00 , A61P7/00 , A61P35/02 , G01N33/574 , A61P37/00
CPC分类号: G01N33/57434 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158 , G01N2800/52
摘要: The present invention provides a biomarker for selecting a patient for treatment with gossypol, wherein the biomarker comprises an elevated expression level of c-Myc, Mcl-1, or combination thereof, relative to the normal expression level of c-Myc, Mcl-1, or combination thereof. The present invention also provides methods for targeting patients for treatment with gossypol, wherein the patient has a disease, condition, or disorder that overexpresses c-Myc, Mcl-1, or combination thereof. The present invention also provides methods for treating or ameliorating a disease, condition, or disorder in a patient comprising determining the expression level of c-Myc, Mcl-1, or combination thereof in the patient and administering gossypol to the patient. In certain embodiments of the invention, the disease is cancer, and the cancer cells show elevated expression levels of c-Myc compared to non-cancerous cells. The invention also provides methods for overcoming Mcl-1-mediated chemoresistance comprising administering gossypol to a patient in need thereof.
摘要翻译: 本发明提供了一种用于选择用棉酚处理的患者的生物标志物,其中相对于c-Myc,Mcl-1的正常表达水平,生物标志物包含c-Myc,Mcl-1或其组合的升高的表达水平 ,或其组合。 本发明还提供了靶向患者用棉酚治疗的方法,其中患者具有过表达c-Myc,Mcl-1或其组合的疾病,病症或病症。 本发明还提供了用于治疗或改善患者疾病,病症或障碍的方法,包括确定患者中c-Myc,Mcl-1或其组合的表达水平,并向患者施用棉酚。 在本发明的某些实施方案中,该疾病是癌症,与非癌细胞相比,癌细胞表现出c-Myc的升高的表达水平。 本发明还提供克服Mcl-1介导的化学耐药性的方法,包括向有需要的患者施用棉酚。
-
公开(公告)号:US20110319362A1
公开(公告)日:2011-12-29
申请号:US13128941
申请日:2009-12-07
申请人: Shaomeng Wang , Jianyong Chen , Cindy Gomez , Longchuan Bai , Zaneta Nikolovska-Coleska , Yu-Jun Zhao
发明人: Shaomeng Wang , Jianyong Chen , Cindy Gomez , Longchuan Bai , Zaneta Nikolovska-Coleska , Yu-Jun Zhao
IPC分类号: A61K31/675 , C07D487/04 , A61P35/00 , A61K31/407 , A61K31/4178 , C07F9/6561 , C07D495/04
CPC分类号: C07D403/12 , A61K31/41 , C07D487/04
摘要: Inhibitors of STAT3 are disclosed. Methods of using the STAT3 inhibitors in the treatment of diseases and conditions wherein inhibition of STAT3 provides a benefit, like cancers, also are disclosed.
摘要翻译: 公开了STAT3的抑制剂。 还公开了使用STAT3抑制剂治疗其中抑制STAT3提供益处的疾病和病症的方法,如癌症。
-
-
-